ArticleCell reports. Medicine2022

Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19.

Dorien Feyaerts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.